The DOI matches its Crossref record; 501 of the 514 references it cites were found in a registry or an index.
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
Open accessAbstract
Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) regulates the basal and stress-inducible expression of a battery of genes encoding key components of the glutathione-based and thioredoxin-based antioxidant systems, as well as aldo-keto reductase, glutathione S-transferase, and Nad(p)h quinone oxidoreductase-1 drug-metabolizing isoenzymes along with multidrug-resistance-associated efflux pumps. It therefore plays a pivotal role in both intrinsic resistance and cellular adaptation to reactive oxygen species (ROS) and xenobiotics. Activation of Nrf2 can, however, serve as a double-edged sword because some of the genes it induces may contribute to chemical carcinogenesis by promoting futile redox cycling of polycyclic aromatic hydrocarbon metabolites or confer resistance to chemotherapeutic drugs by increasing the expression of efflux pumps, suggesting its cytoprotective effects will vary in a context-specific fashion. In addition to cytoprotection, Nrf2 also controls genes involved in intermediary metabolism, positively regulating those involved in NADPH generation, purine biosynthesis, and the β-oxidation of fatty acids, while suppressing those involved in lipogenesis and gluconeogenesis. Nrf2 is subject to regulation at multiple levels. Its ability to orchestrate adaptation to oxidants and electrophiles is due principally to stress-stimulated modification of thiols within one of its repressors, the Kelch-like ECH-associated protein 1 (Keap1), which is present in the cullin-3 RING ubiquitin ligase (CRL) complex CRLKeap1. Thus modification of Cys residues in Keap1 blocks CRLKeap1 activity, allowing newly translated Nrf2 to accumulate rapidly and induce its target genes. The ability of Keap1 to repress Nrf2 can be attenuated by p62/sequestosome-1 in a mechanistic target of rapamycin complex 1 (mTORC1)-dependent manner, thereby allowing refeeding after fasting to increase Nrf2-target gene expression. In parallel with repression by Keap1, Nrf2 is also repressed by β-transducin repeat-containing protein (β-TrCP), present in the Skp1-cullin-1-F-box protein (SCF) ubiquitin ligase complex SCFβ-TrCP. The ability of SCFβ-TrCP to suppress Nrf2 activity is itself enhanced by prior phosphorylation of the transcription factor by glycogen synthase kinase-3 (GSK-3) through formation of a DSGIS-containing phosphodegron. However, formation of the phosphodegron in Nrf2 by GSK-3 is inhibited by stimuli that activate protein kinase B (PKB)/Akt. In particular, PKB/Akt activity can be increased by phosphoinositide 3-kinase and mTORC2, thereby providing an explanation of why antioxidant-responsive element-driven genes are induced by growth factors and nutrients. Thus Nrf2 activity is tightly controlled via CRLKeap1 and SCFβ-TrCP by oxidative stress and energy-based signals, allowing it to mediate adaptive responses that restore redox homeostasis and modulate intermediary metabolism. Based on the fact that Nrf2 influences multiple biochemical pathways in both positive and negative ways, it is likely its dose-response curve, in terms of susceptibility to certain degenerative disease, is U-shaped. Specifically, too little Nrf2 activity will lead to loss of cytoprotection, diminished antioxidant capacity, and lowered β-oxidation of fatty acids, while conversely also exhibiting heightened sensitivity to ROS-based signaling that involves receptor tyrosine kinases and apoptosis signal-regulating kinase-1. By contrast, too much Nrf2 activity disturbs the homeostatic balance in favor of reduction, and so may have deleterious consequences including overproduction of reduced glutathione and NADPH, the blunting of ROS-based signal transduction, epithelial cell hyperplasia, and failure of certain cell types to differentiate correctly. We discuss the basis of a putative U-shaped Nrf2 dose-response curve in terms of potentially competing processes relevant to different stages of tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This interaction is mediated by a 349DPSTGE354 motif in p62’s Keap1-interacting region (KIR) that resembles the ETGE motif in the Keap1-binding domain of Nrf2 [79,80,81].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [79]
In the citing paper
“In response to elevated levels of reactive oxygen species (ROS) and environmental toxins or to nutrient and metabolic changes through mTOR signaling and insulin/IGF signaling, NRF/SKN-1 activates the expression of genes involved in cellular protection (Blackwell et al., 2015; Tebay et al., 2015).”
From The Aging Epigenome (2016) · cites this paper as Tebay et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–501 of 501
Complexity of CNC Transcription Factors As Revealed by Gene Targeting of the Nrf3 Locus
Derjuga, A., Gourley, T. S., Holm, T. M., Heng, H. H. Q., Shivdasani, R. A., Ahmed, R., Andrews, N. C., & Blank, V. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3286-3294.2004 · Cited by 100
Dagnell, M., Frijhoff, J., Pader, I., Augsten, M., Boivin, B., Xu, J., Mandal, P. K., Tonks, N. K., Hellberg, C. B., Conrad, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302891110 · Cited by 100
Deficiency in Nrf2-GSH Signaling Impairs Type II Cell Growth and Enhances Sensitivity to Oxidants
Reddy, N. M., Kleeberger, S. R., Cho, H., Yamamoto, M. P., Kensler, T. W., Biswal, S. S., & Reddy, S. P. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0004rc · Cited by 98
Kim, S. S., Lim, J., Bang, Y., Gal, J., Lee, S., Cho, Y.-C., Yoon, G., Kang, B. Y., Cheon, S. H., & Choi, H. J. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.07.012 · Cited by 97
Yeang, H. X. A., Hamdam, J. M., Al-Huseini, L. M. A., Sethu, S., Djouhri, L., Walsh, J., Kitteringham, N. R., Park, B. K., Goldring, C. E., & Sathish, J. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.322420 · Cited by 97
LKB1/AMPK/mTOR Signaling Pathway in Non-small-cell Lung Cancer
Han, D. G., Li, S., Zhu, Y., Liu, L., & Li, M. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.7.4033 · Cited by 97
The antioxidant machinery of the endoplasmic reticulum: Protection and signaling
Delaunay, A., & Appenzeller‐Herzog, C. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.019 · Cited by 97
Boivin, B., Zhang, S., Arbiser, J. L., Zhang, Z., & Tonks, N. K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804336105 · Cited by 96
Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy
Kannan, S., Muthusamy, V. R., Whitehead, K. J., Wang, L., Gomes, A. V., Litwin, S. E., Kensler, T. W., Abel, E. D., Hoidal, J. R., & Rajasekaran, N. S. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt150 · Cited by 96
Targeted Deletion of Nrf2 Reduces Urethane-Induced Lung Tumor Development in Mice
Bauer, A. K., Cho, H., Miller‐DeGraff, L., Walker, C., Helms, K. L., Fostel, J. M., Yamamoto, M. P., & Kleeberger, S. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026590 · Cited by 95
Hayes, J. D., Judah, D. J., Neal, G. E., & Nguyen, T. H. (1992) · Biochemical Journal · doi:10.1042/bj2850173 · Cited by 95
Self-citationGenetic Activation of Nrf2 Protects against Fasting-Induced Oxidative Stress in Livers of Mice
Zhang, Y.-K. J., Wu, K. C., & Klaassen, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059122 · Cited by 94
Lee, C. S., Ho, D. V., & Chan, J. Y. (2013) · FEBS Journal · doi:10.1111/febs.12350 · Cited by 94
Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet
Zhang, Y.-K. J., Wu, K. C., Liu, J., & Klaassen, C. D. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.09.014 · Cited by 93
Miao, X., Bai, Y., Sun, W., Cui, W., Xin, Y., Wang, Y., Tan, Y., Miao, L., Fu, Y., Su, G., et al. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-84 · Cited by 93
Suzuki, T., Kelly, V. P., Motohashi, H., Nakajima, O., Takahashi, S., Nishimura, S., & Yamamoto, M. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708352200 · Cited by 92
Selenium deficiency activates mouse liver Nrf2–ARE but vitamin E deficiency does not
Burk, R. F., Hill, K. E., Nakayama, A., Mostert, V., Levander, X. A., Motley, A. K., Johnson, D. A., Johnson, J. A., Freeman, M. L., & Austin, L. M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.016 · Cited by 90
KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma
Li, Q. K., Singh, A., Biswal, S., Askin, F., & Gabrielson, E. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2010.172 · Cited by 90
Ilic, Z., Crawford, D. R., Egner, P. A., & Sell, S. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.10.008 · Cited by 90
Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
Liby, K. T., Royce, D. B., Risingsong, R., Williams, C. R., Maitra, A., Hruban, R. H., & Sporn, M. B. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0197 · Cited by 90
Okada, K., Warabi, E., Sugimoto, H., Horie, M., Gotoh, N., Tokushige, K., Hashimoto, E., Utsunomiya, H., Takahashi, H., Ishii, T., et al. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0659-z · Cited by 89
The spatiotemporal regulation of the Keap1–Nrf2 pathway and its importance in cellular bioenergetics
Dinkova‐Kostova, A. T., Baird, L., Holmström, K. M., Meyer, C. J., & Abramov, A. Y. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150003 · Cited by 86
Self-citationSherratt, P. J., Manson, M. M., THOMSON, A. M., Hissink, E. M., Neal, G. E., van BLADEREN, P. J., Green, T., & Hayes, J. D. (1998) · Biochemical Journal · doi:10.1042/bj3350619 · Cited by 85
Self-citationOxidation of PAH trans-Dihydrodiols by Human Aldo-Keto Reductase AKR1B10
Quinn, A. M., Harvey, R. G., & Penning, T. M. (2008) · Chemical Research in Toxicology · doi:10.1021/tx8002005 · Cited by 83
Self-citationAppenzeller‐Herzog, C., & Ellgaard, L. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1837 · Cited by 82
Trafficking of the Transcription Factor Nrf2 to Promyelocytic Leukemia-Nuclear Bodies
Theodore, M., McIntosh, D., Walters, T. S., Flores, A., Goodwin, J. S., & Arinze, I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437392 · Cited by 82
Decline in DJ-1 and Decreased Nuclear Translocation of Nrf2 in Fuchs Endothelial Corneal Dystrophy
Bitar, M. S., Cai-ling, L., Ziaei, A., Chen, Y., Schmedt, T., & Jurkunas, U. V. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10119 · Cited by 80
Veliça, P., Davies, N., Rocha, P. P., Schrewe, H., Ride, J. P., & Bunce, C. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-121 · Cited by 80
Balancing oxidative protein folding: The influences of reducing pathways on disulfide bond formation
Kojer, K., & Riemer, J. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.02.004 · Cited by 79
Birtwistle, J., Hayden, R. E., Khanim, F. L., Green, R. M., Pearce, C., Davies, N., Wake, N. C., Schrewe, H., Ride, J. P., Chipman, J. K., et al. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.12.010 · Cited by 79
Tsujita, T., Peirce, V. J., Baird, L., Matsuyama, Y., Takaku, M., Walsh, S. V., Griffin, J. L., Uruno, A., Yamamoto, M. P., & Hayes, J. D. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00110-14 · Cited by 78
Self-citationGenetic associations of Nrf2-encoding NFE2L2 variants with Parkinson’s disease – a multicenter study
von Otter, M., Bergström, P., Quattrone, A., Marco, E. V. D., Annesi, G., Söderkvist, P., Wettinger, S. B., Droździk, M., Białecka, M. A., Nissbrandt, H., et al. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0131-4 · Cited by 77
Velmurugan, G. V., Sundaresan, N. R., Gupta, M. P., & White, C. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt125 · Cited by 76
Atalla, A., Breyer-Pfaff, U., & Maser, E. (2000) · Xenobiotica · doi:10.1080/00498250050119826 · Cited by 75
Zhang, Y., Kobayashi, A., Yamamoto, M. P., & Hayes, J. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805337200 · Cited by 75
Self-citationGoettsch, C., Göettsch, W., Brux, M., Haschke, C., Brunßen, C., Müller, G. M., Bornstein, S. R., Duerrschmidt, N., Wagner, A. H., & Morawietz, H. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0170-3 · Cited by 75
Fishel, M. L., Wu, X. Z., Devlin, C. M., Logsdon, D. P., Jiang, Y., Luo, M., He, Y., Yu, Z., Tong, Y., Lipking, K. P., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.621995 · Cited by 74
Hayes, J. D., Nguyen, T. H., Judah, D. J., Petersson, D. G., & Neal, G. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32050-1 · Cited by 73
Self-citationJowsey, I. R., Jiang, Q., Itoh, K., Yamamoto, M. P., & Hayes, J. D. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1018 · Cited by 73
Self-citationBecks, L., Prince, M., Burson, H. C., Christophe, C., Broadway, M., Itoh, K., Yamamoto, M. P., Mathis, J. M., Orchard, E. A., Shi, R., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-540 · Cited by 71
Kang, H. J., Hong, Y. B., Kim, H. J., & Bae, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.084590 · Cited by 71
Balanced Ero1 activation and inactivation establishes ER redox homeostasis
Kim, S., Sideris, D. P., Sevier, C. S., & Kaiser, C. A. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201110090 · Cited by 70
Substrate specificity of an aflatoxin-metabolizing aldehyde reductase
Ellis, E. M., & Hayes, J. D. (1995) · Biochemical Journal · doi:10.1042/bj3120535 · Cited by 69
Self-citationNovel directions for diabetes mellitus drug discovery
Maiese, K., Chong, Z. Z., Shang, Y., & Wang, S. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.736485 · Cited by 69
Oxidative stress activates the c-Abl/p73 proapoptotic pathway in Niemann-Pick type C neurons
Klein, A. D., Maldonado, C., Vargas, L. M., Gonzalez, M., Robledo, F., de Arce, K. P., Muñoz, F. J., Hetz, C. A., Alvarez, A. R., & Zanlungo, S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.008 · Cited by 68
Threonine 41 in β-Catenin Serves as a Key Phosphorylation Relay Residue in β-Catenin Degradation
Wu, G., & He, X. (2006) · Biochemistry · doi:10.1021/bi0601149 · Cited by 68
Steckelbroeck, S., Oyesanmi, B., Jin, Y., Lee, S. H., Kloosterboer, H. J., & Penning, T. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.091587 · Cited by 66
Self-citationWNT-3A Regulates an Axin1/NRF2 Complex That Regulates Antioxidant Metabolism in Hepatocytes
Rada, P., Rojo, A. I., Offergeld, A., Feng, G. J., Velasco-Martin, J. P., González‐Sancho, J. M., Valverde, Á. M., Dale, T. C., Regadera, J., & Cuadrado, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6040 · Cited by 65
Miura, T., Shinkai, Y., Jiang, H., Iwamoto, N., Sumi, D., Taguchi, K., Yamamoto, M. P., Jinno, H., Tanaka‐Kagawa, T., Cho, A. K., et al. (2011) · Chemical Research in Toxicology · doi:10.1021/tx100427p · Cited by 65
Steckelbroeck, S., Jin, Y., Oyesanmi, B., Kloosterboer, H. J., & Penning, T. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004515 · Cited by 64
Self-citationAnalyses of Glutathione Reductase Hypomorphic Mice Indicate a Genetic Knockout
Rogers, L. K. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh268 · Cited by 64
McLellan, L. I., & Hayes, J. D. (1989) · Biochemical Journal · doi:10.1042/bj2630393 · Cited by 63
Self-citationWeerachayaphorn, J., Mennone, A., Soroka, C. J., Harry, K., Hagey, L. R., Kensler, T. W., & Boyer, J. L. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00263.2011 · Cited by 62
Whysner, J. A. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00066-6 · Cited by 62
Patterson, A. D., Carlson, B. A., Li, F., Bonzo, J. A., Yoo, M., Krausz, K. W., Conrad, M., Chen, C., Gonzalez, F. J., & Hatfield, D. L. (2013) · Chemical Research in Toxicology · doi:10.1021/tx4001013 · Cited by 62
To, C., Ringelberg, C. S., Royce, D. B., Williams, C. R., Risingsong, R., Sporn, M. B., & Liby, K. T. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv061 · Cited by 62
Nrf2 deficiency causes tooth decolourization due to iron transport disorder in enamel organ
Yanagawa, T., Itoh, K., Uwayama, J., Shibata, Y., Yamaguchi, A., Sano, T., Ishii, T., Yoshida, H., & Yamamoto, M. P. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00753.x · Cited by 61
Seven in Absentia Homolog 2 (Siah2) Protein Is a Regulator of NF-E2-related Factor 2 (Nrf2)*
Baba, K., Morimoto, H., & Imaoka, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438762 · Cited by 60
Lv, P., Miao, S., Shu, Y.-N., Dong, L., Liu, C., Xie, X., Gao, M., Wang, Y.-C., Yin, Y., Wang, X., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.272013 · Cited by 59
Keap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feeding
More, V. R., Xu, J., Shimpi, P. C., Belgrave, C., Luyendyk, J. P., Yamamoto, M. P., & Slitt, A. L. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.007 · Cited by 58
Breyer-Pfaff, U., Martin, H.-J., Ernst, M., & Maser, E. (2004) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)02973-8 · Cited by 58
CDDO-Methyl Ester Delays Breast Cancer Development in Brca1-Mutated Mice
Kim, E., Deng, C., Sporn, M. B., Royce, D. B., Risingsong, R., Williams, C. R., & Liby, K. T. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0359 · Cited by 57
Liby, K. T., Risingsong, R., Royce, D. B., Williams, C. R., Ma, T., Yore, M. M., & Sporn, M. B. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0085 · Cited by 57
Xu, J., Donepudi, A. C., Moscovitz, J. E., & Slitt, A. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079841 · Cited by 56
Tanaka, Y., Ikeda, T., Yamamoto, K., Ogawa, H., & Kamisako, T. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07180.x · Cited by 53
Jiang, Z., Chu, H., Xi, M., Yang, T., Jia, J.-M., Huang, J., Guo, X., Zhang, X., You, Q., & Sun, H.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075076 · Cited by 52
Stiborová, M., Dračínská, H., Hájková, J., Kadeřábková, P., Frei, E., Schmeiser, H. H., Souček, P., Phillips, D. H., & Arlt, V. M. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009373 · Cited by 52
Liby, K. T., Yore, M. M., Roebuck, B. D., Baumgartner, K. J., Honda, T., Sundararajan, C., Yoshizawa, H., Gribble, G. W., Williams, C. R., Risingsong, R., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1123 · Cited by 52
Self-citationMeher, A. K., Sharma, P. R., Lira, V. A., Yamamoto, M. P., Kensler, T. W., Yan, Z., & Leitinger, N. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.022 · Cited by 51
Time now to TORC the TORC ? New developments in m TOR pathway inhibition in lymphoid malignancies
Eyre, T. A., Collins, G. P., Goldstone, A. H., & Cwynarski, K. (2014) · British Journal of Haematology · doi:10.1111/bjh.12945 · Cited by 49
Human ABC transporters ABCG2 (BCRP) and ABCG4
Koshiba, S., An, R., Saito, H., Wakabayashi, K., Tamura, A., & Ishikawa, T. (2008) · Xenobiotica · doi:10.1080/00498250801986944 · Cited by 47
Rendić, S., & Guengerich, F. P. (2012) · Current Drug Metabolism · doi:10.2174/138920012800840356 · Cited by 47
Garcı́a, E., Santana-Martínez, R. A., Silva‐Islas, C. A., Colín-González, A. L., Galván‐Arzate, S., Heras‐Romero, Y., Maldonado, P. D., Sotelo, J., & Santamarı́a, A. (2013) · Free Radical Research · doi:10.3109/10715762.2013.857019 · Cited by 44
Upadhyaya, P., Carmella, S. G., Guengerich, F. P., & Hecht, S. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.6.1233 · Cited by 44
McLeod, R., Ellis, E. M., Arthur, J. R., Neal, G. E., Judah, D. J., Manson, M. M., & Hayes, J. D. (1997) · PubMed · Cited by 43
Self-citationMcLellan, L. I., Kerr, L. A., Cronshaw, A. D., & Hayes, J. D. (1991) · Biochemical Journal · doi:10.1042/bj2760461 · Cited by 43
Self-citationDahl, E. L. (2001) · Toxicological Sciences · doi:10.1093/toxsci/61.2.265 · Cited by 42
Takeuchi, K., Morizane, Y., Kamami-Levy, C., Suzuki, J., Kayama, M., Cai, W., Miller, J. W., & Vavvas, D. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.460832 · Cited by 41
Kelleher, M., McMahon, M. J., Eggleston, I. M., Dixon, M. J., Taguchi, K., Yamamoto, M. P., & Hayes, J. D. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp182 · Cited by 40
Self-citationRegulation of carbonyl-reducing enzymes in rat liver by chemoprotectors.
Ellis, E. M., Judah, D. J., Neal, G. E., O'Connor, T., & Hayes, J. D. (1996) · PubMed · Cited by 39
Self-citationMa, X. H. Q. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s7-002 · Cited by 39
Li, Y., Zahid, M., Liao, Y., Rogan, E. G., Cavalieri, E. L., Davidson, N. E., Yager, J. D., Visvanathan, K., Groopman, J. D., & Kensler, T. W. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt246 · Cited by 37
Stiborová, M., Frei, E., Schmeiser, H. H., Arlt, V. M., & Martínek, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150610271 · Cited by 36
Galuppo, M., Iori, R., Nicola, G. R. D., Bramanti, P., & Mazzon, E. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.065 · Cited by 35
Stiborová, M., Dračínská, H., Mizerovská, J., Frei, E., Schmeiser, H. H., Hudeček, J., Hodek, P., Phillips, D. H., & Arlt, V. M. (2008) · Toxicology · doi:10.1016/j.tox.2008.01.018 · Cited by 34
Two Allelic Variants of Aldo-Keto Reductase 1A1 Exhibit Reduced in Vitro Metabolism of Daunorubicin
Bains, O. S., Takahashi, R., Pfeifer, T. A., Grigliatti, T. A., Reid, R. E., & Riggs, K. W. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018895 · Cited by 34
Characterization of Two Thioredoxins in Pig Heart Including a New Mitochondrial Protein
Bodenstein, J., & Follmann, H. (1991) · Zeitschrift für Naturforschung C · doi:10.1515/znc-1991-3-418 · Cited by 33
Lam, L. K. T., Sparnins, V. L., Hochalter, J. B., & Wattenberg, L. W. (1981) · PubMed · Cited by 32
Promoter DNA demethylation of Keap1 gene in diabetic cardiomyopathy.
Liu, Z.-Z., Zhao, X.-Z., Zhang, X., & Zhang, M. (2014) · Europe PMC (PubMed Central) · Cited by 30
Introduction to Drug Metabolism
Corcoran, G. B. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600760322 · Cited by 30
Genomics of Smoking Exposure and Cessation: Lessons for Cancer Prevention and Treatment
Penning, T. M., & Lerman, C. E. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0047 · Cited by 30
Self-citationKang, S. W. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6437-z · Cited by 27
Specificity, location and function of βTrCP isoforms and their splice variants
Putters, J., Slotman, J. A., Gerlach, J. P., & Strous, G. J. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.015 · Cited by 25
Kensler, K. H., Slocum, S. L., Chartoumpekis, D. V., Dolan, P. M., Johnson, N. M., Ilic, Z., Crawford, D. R., Sell, S., Groopman, J. D., Kensler, T. W., et al. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu056 · Cited by 25
Aleksunes, L. M., Yeager, R. L., & Klaassen, C. D. (2009) · Xenobiotica · doi:10.1080/00498250902952514 · Cited by 24
Selective Induction of Liver Parenchymal Cell Heme Oxygenase-1 in Selenium-Deficient Rats
Mostert, V., Hill, K. E., Ferris, C. D., & Burk, R. F. (2003) · Biological Chemistry · doi:10.1515/bc.2003.076 · Cited by 21
Jin, Y., Duan, L., Chen, M., Penning, T. M., & Kloosterboer, H. J. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.12.002 · Cited by 18
Self-citationCan metabolic plasticity be a cause for cancer? Warburg–Waddington legacy revisited
Bhat, P. J., Darunte, L. A., Kareenhalli, V. V., Dandekar, J. U., & Kumar, A. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0030-x · Cited by 16
Varma, S. D., Chandrasekaran, K., & Ковтун, С. И. (2013) · Clinical ophthalmology · doi:10.2147/opth.s52678 · Cited by 16
Kozma, E., Brown, E. H., Ellis, E. M., & Lapthorn, A. J. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00186-2 · Cited by 10
Meissner (1957) · doi:10.1002/1097-0142(195705/06)10:3
Cited by
Sorted by citations
Transcriptional Regulation by Nrf2
Tonelli, C., Chio, I. I. C., & Tuveson, D. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7342 · Cited by 2,280
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,510
Self-citationNrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130
ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age‐Related Diseases
Davalli, P., Mitic, T., Caporali, A., Lauriola, A., & D’Arca, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3565127 · Cited by 1,059
Metadata
- Authors
- Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D.
- Affiliations
- University of Dundee (GB)
- AstraZeneca (United Kingdom) (GB)
- University of Pennsylvania (US)
- Corresponding author
- Hayes, John D.
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 88
- Issue
- Pt B
- Pages
- 108-146
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC4659505
- OpenAlex
- W1421415727
- Cited by
- 837
- References
- 514
- Citations by year
- 2026: 56 · 2025: 54 · 2024: 65 · 2023: 89 · 2022: 90 · 2021: 92 · 2020: 103 · 2019: 88 · 2018: 72 · 2017: 75 · 2016: 45 · 2015: 7
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Funders
- Cancer Research UK (C4909/A13786)
- MRC (MR/J001465/1)
- MRC ITTP (1313992)
- BBSRC Industrial CASE (BB/L01405X/1)
- BBSRC (BB/L01923X/1, P30-ES013508)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2, redox stress, Keap1, mTORC1, p62/sequestosome 1, nutrient sensing, energy status, reactive oxygen species, xenobiotic metabolism, drug resistance, multidrug resistance, glutathione, thioredoxin, antioxidant defense, degenerative diseases
- MeSH terms
- Animals, Humans, Oxidation-Reduction, Signal Transduction, Oxidative Stress, NF-E2-Related Factor 2, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review